Keyphrases
Psychostimulant Abuse
100%
D3 Dopamine Receptor
100%
D3 Receptor
100%
Functional Selectivity
50%
Intrinsic Activity
50%
Psychostimulants
50%
Drug Addiction
33%
Binding Selectivity
33%
D2 Dopamine Receptor
33%
Substituted Phenyl
16%
Functional Properties
16%
Drugability
16%
Design Testing
16%
Trifluoromethylphenylpiperazine (TFMPP)
16%
Pharmacological Characterization
16%
Binding Assay
16%
Cocaine-seeking Behavior
16%
Potential Therapeutics
16%
Preclinical Testing
16%
Partial Agonist
16%
Adenylyl Cyclase
16%
In Vivo Efficacy
16%
Treatment Agent
16%
Selective Antagonist
16%
D2 Receptor
16%
Inhibition Assay
16%
Binding Activity
16%
Cocaine Abuse
16%
Progressive Ratio Schedule
16%
Fixed Ratio
16%
Subtype Selectivity
16%
Pharmaceutics
16%
Low Affinity
16%
Electrophysiology
16%
Receptor Selectivity
16%
Receptor-based
16%
High Affinity
16%
Addition Compounds
16%
Cocaine
16%
Binding Site
16%
Log P Value
16%
Blood-brain Barrier
16%
Rodent Models
16%
Potential Treatments
16%
Reinforcing Properties
16%
Self-administration
16%
Signaling Pathway
16%
In Vivo Evaluation
16%
Nucleus Accumbens
16%
Locomotor Activity
16%
Neuroscience
Receptor
100%
Psychostimulant
100%
Receptor Subtype
66%
Functional Selectivity
50%
In Vivo
33%
In Vitro
33%
Dopamine Receptor D2
33%
Agonist
33%
Dopamine Receptor D3
33%
Binding Site
16%
Cell Signaling
16%
Electrophysiology
16%
Behavior (Neuroscience)
16%
Cocaine Abuse
16%
Adenylyl Cyclase
16%
Blood Brain Barrier
16%
Nucleus Accumbens
16%
Locomotor Activity
16%
Piperazine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Psychostimulant
100%
Receptor Subtype
66%
Intrinsic Activity
50%
Functional Selectivity
50%
Drug Dependence
33%
Binding Selectivity
33%
Dopamine Receptor D2
33%
Dopamine 3 Receptor
33%
Blood-Brain Barrier
16%
Partial Agonist
16%
Binding Site
16%
Piperazine
16%
Adenylate Cyclase
16%